drugset / Trial / NCT01986270
Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this study was to compare the efficacy, toleration and safety of eletriptan 40mg and 80mg, with sumatriptan 25mg and 50mg, and placebo when given orally to subjects with an acute migraine.
Timeline
- Start
- 1996-12
- Primary completion
- 1998-01
- Completion
- 1998-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eletriptan | Small molecule | 40 mg | Oral |
| Subject | Eletriptan | Small molecule | 80 mg | Oral |
| Subject | Sumatriptan | Unknown | 25 mg | Oral |
| Subject | Sumatriptan | Unknown | 50 mg | Oral |